Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes

Share this content:

Men with high-risk prostate cancer who take statins while receiving radiation therapy may be less likely to have their cancer return than patients who do not take these cholesterol-lowering agents. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters